-
د.إ3,500.00
The 24G Pharmacogenomics plus DNA Test is a cutting-edge genetic analysis that provides personalized insights into drug response and overall health. It examines pharmacogenomics, helping to predict how your body metabolizes medications, reducing adverse drug reactions and optimizing treatment plans. Additionally, it includes a comprehensive DNA test covering traits, wellness, and genetic predispositions. Key benefits include personalized medication guidance, enhanced treatment safety, and actionable health insights.
Sample Type : Saliva
Methodology : Illumina
TAT : 3-6 Weeks
-
د.إ599.00
Down Risk 1st Trimester Screening offers unparalleled value by combining accuracy, safety, and early insight into your baby’s development. It empowers parents with critical information at a pivotal time, fostering confidence and informed decision-making throughout the pregnancy.
| Down’s Risk : 1st Trimester |
| Parameters |
| Free B-Hcg |
| PAPP-A |
|
| 11 TO 13 Weeks + 6 days |
-
د.إ3,400.00
The Fragile X (FMR1) Mutation Screen (L) is a genetic test designed to detect mutations in the FMR1 gene, which are associated with Fragile X syndrome, a leading cause of inherited intellectual disability and autism. This screening identifies CGG repeat expansions, distinguishing between normal, premutation, and full mutation alleles. Key benefits include early detection for informed reproductive decisions, risk assessment for carriers, and guidance for personalized medical management. Utilizing advanced molecular techniques, the test ensures high accuracy and reliability. Ideal for individuals with a family history of Fragile X or unexplained developmental delays, this screening provides critical genetic insights for proactive healthcare planning.
-
د.إ4,000.00
The **Hereditary Cancer Gene Panel (57 ACMG Genes)** is a comprehensive genetic test designed to assess inherited cancer risk by analyzing 57 clinically significant genes recommended by the **American College of Medical Genetics (ACMG)**. This panel identifies mutations linked to various hereditary cancers, including **breast, ovarian, colorectal, prostate, and pancreatic cancers**, enabling early detection and personalized risk management. Key features include **next-generation sequencing (NGS) technology** for high accuracy, expert-reviewed results, and actionable insights for **preventive care and targeted treatment strategies**. Ideal for individuals with a family history of cancer, this test empowers proactive healthcare decisions, offering **lifelong benefits through early intervention and precision medicine**.
-
د.إ4,000.00
The **Hereditary Cancer Panel 57 ACMG 20 HBOC & 865 Literature-Reviewed Genes** is a comprehensive genetic test designed to assess hereditary cancer risk. It analyzes **57 key genes**, including the **ACMG 20** and **HBOC-related genes**, alongside **865 literature-reviewed genes**, ensuring a thorough evaluation of cancer predisposition. This panel covers a wide range of hereditary cancers, including **breast, ovarian, colorectal, and more**, providing **clinically actionable insights** for early detection and personalized risk management. Utilizing **advanced sequencing technology**, it delivers **high accuracy and reliability**, making it an essential tool for **patients, healthcare providers, and genetic counselors**. Its unique combination of **expert-curated genes and extensive literature review** enhances diagnostic precision, setting it apart as a **cutting-edge solution for hereditary cancer risk assessment**.
-
د.إ3,200.00
PredictLife Test is a cutting-edge DNA-based health and longevity assessment that provides personalized insights into your genetic predispositions, lifestyle risks, and potential health outcomes. Using advanced AI and genomic analysis, it evaluates factors like disease risks, aging patterns, nutrition, and fitness optimization.
-
د.إ650.00
The Triple Test: Comprehensive Screening for Maternal and Fetal Health is a non-invasive prenatal blood test that evaluates three key biomarkers—AFP, hCG, and estriol—to assess the risk of fetal chromosomal abnormalities such as Down syndrome and neural tube defects.
Sample Type : Serum
Methodology : Enzyme-immunoassay
TAT : 3 Days
